Abstract:BACKGROUND:Stem cell transplantation offers a promising treatment for heart failure. Recent studies show that both c-kit positive cardiac stem cells (CSCs) and bone marrow-derived mesenchymal stem cells (BM-MSCs) are good candidates for stem cell therapy to treat heart failure; however, the exact mechanism of stem cell therapy in improving cardiac function of ischemic cardiomyopathy is not fully known. Our objective was to test our hypothesis that CSCs and/or BM-MSCs repair the damaged heart by boosting post-myocardial infarction (MI) angiogenesis in a paracrine manner. METHODS AND RESULTS:We isolated and purified CSCs and BM-MSCs from rats. Intramyocardial injections of CSCs and/or BM-MSCs were performed at 28 days after MI. We applied cardiac ultrasound and histological analysis to evaluate the effect of cell therapy on cardiac function and cardiac remodeling. In vivo donor cell transplantation experiments showed that CSCs and/or BM-MSCs improved cardiac function after MI and reduced infarct size. However, in vivo cell tracking experiments showed that minimal donor cells remained in the myocardium after cell transplantation. Our further in vitro and in vivo experiments showed that transplantation of CSCs enhanced the expression of pro-angiogenic factors and boosted post-MI angiogenesis in the myocardium in a paracrine manner, which in part contributed to the effect of CSCs on cardiac recovery after MI. CSCs and BM-MSCs synergistically inhibited CSC/BM-MSC apoptosis and enhanced their proliferation in a paracrine manner. This resulted in a larger number of transplanted cells remaining in the post-MI myocardium after coinjection of CSCs and BM-MSCs, and therefore the accumulation of more pro-angiogenic factors in the heart tissue compared to transplantation of CSCs or MSCs alone. Consequently, transplantation of both CSCs and BM-MSCs was superior to transplantation of either CSCs or BM-MSCs alone to boost post-MI angiogenesis and improve cardiac function after MI. CONCLUSION:C-kit+ CSC and/or BM-MSC transplantation can improve cardiac function after MI in a paracrine manner. Coinjection of both CSCs and BM-MSCs improves cardiac function more significantly than CSC or BM-MSC transplantation alone in a paracrine manner by improving the engraftment of donor cells and boosting the expression of multiple pro-angiogenic factors.

SCF/c-kit transactivates CXCR4-serine 339 phosphorylation through G protein-coupled receptor kinase 6 and regulates cardiac stem cell migration

Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK

Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor.

bFGF promotes Sca‑1+ cardiac stem cell migration through activation of the PI3K/Akt pathway

Regulation of C-Kit+ Progenitor Cells by Stromal Cell Derived Factor-1Α in Adult Murine Heart.

Epigenetic Regulation of Cardiac Progenitor Cells Marker C-Kit by Stromal Cell Derived Factor-1α

Mir-466 Regulates the Migration of ADSCs in Repairing Cutaneous Wound Via Targeting SCF/c-kit/ERK Signaling Axis

Cardiac stem cells transplantation enhances the expression of connexin 43 via the ANG II/AT1R/TGF-beta1 signaling pathway in a rat model of myocardial infarction.

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

A Critical Role of Src Family Kinase in SDF-1/CXCR4-mediated Bone-Marrow Progenitor Cell Recruitment to the Ischemic Heart

Insulin-like growth factor-1-mediated regulation of miR-193a expression promotes the migration and proliferation of c-kit-positive mouse cardiac stem cells

Setd4 Controlled Quiescent C-Kit+ Cells Contribute to Cardiac Neovascularization of Capillaries Beyond Activation.

CXCR4-Mediated Bone Marrow Progenitor Cell Maintenance and Mobilization Are Modulated by C-Kit Activity

TNF Receptor-Associated Factor 6 (TRAF6) Mediates the Angiotensin-Induced Non-Canonical TGF-β Pathway Activation of C-Kit(+) Cardiac Stem Cells.

Inhibition of Oct 3/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium

Abstract 19996: Cardiac Mesenchymal Stem Cells with High Endogenous Gata4 Promoter Activity Have Superior Capacity to Elicit Cardiac Repair

Clusterin induces CXCR4 expression and migration of cardiac progenitor cells

Abstract 16620: Enhancing Transplanted Cardiac Progenitor Cells Homing and Survival in Ischemic Heart by CRISPR-dcas9/sgRNA-based Endogenous CXCR4 Promoter Activation

Transmyocardial Revascularization Enhances Bone Marrow Stem Cell Engraftment in Infarcted Hearts Through SCF-C-kit and SDF-1-CXCR4 Signaling Axes

SCF/c-Kit-activated signaling and angiogenesis require Gai1 and Gai3

Vascular Endothelial Growth Factor Promotes Cardiac Stem Cell Migration Via the PI3K/Akt Pathway.